Skip to main content
SpringerLink
Log in

Contemporary Management of Urinary Incontinence

  • Chapter
  • First Online:
Urologic Principles and Practice

Part of the book series: Springer Specialist Surgery Series ((SPECIALIST))

  • 1204 Accesses

Abstract

Urinary incontinence is a highly prevalent condition resulting in a significant impact on quality of life. It can be stratified into urgency incontinence, stress incontinence and mixed incontinence. Over time, many treatment options have developed for management of these symptoms. The focus of this chapter is to briefly review the diagnosis, history of treatment and current contemporary treatment options for the management of urinary incontinence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abrams P, Cardozo L, Fall M. The Standardization of terminology of lower urinary tract function. Report from the standardization sub-committee of the ICS. Neurourol Urodyn. 2002;21(2):167–78.

    Article  PubMed  Google Scholar 

  2. Haylen BT, DeRidder D, Freeman RM, et al. Neurourol Urodyn. 2010;29:4–20.

    PubMed  Google Scholar 

  3. Wu JM, Vaughan CP, Goode PS. Prevalence and trends of symptomatic pelvic floor disorders in US Women. Obstet Gynecol. 2014;123(1):141–8.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mor S, Kuhn P, Mueller MD, et al. J Sex Med. 2011;8:1740–56.

    Article  Google Scholar 

  5. Kerr LA. Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile. Rev Urol. 2005;7(Suppl 1):S3–S11.

    PubMed  PubMed Central  Google Scholar 

  6. Subak LL, Wing R, West DS, Franklin F, Vittinghoff E, Creasman JM. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360:481–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ebbesen MH, Hunskaar S, Rortveit G. Prevalence, incidence and remission of urinary incontinence in women: longitudinal data from the Norwegian HUNT study (EPICONT). BMC Urol. 2013;13:27.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Waetjen LE, Liao S, Johnson WO, Sampselle CM, Sternfield B, Harlow SD. Factors associated with prevalent and incident urinary incontinence in a cohort of midlife women: a longitudinal analysis of data: study of women’s health across the nation. Am J Epidemiol. 2007;165:309–18.

    Article  PubMed  Google Scholar 

  9. Danforth KN, Shah AD, Townsend MK, Lifford KL, Curhan GC, Resnick NM. Physical activity and urinary incontinence among healthy, older women. Obstet Gynecol. 2007;109:721–7.

    Article  PubMed  Google Scholar 

  10. DeLancey JO. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol. 1994;170:1713–23.

    Article  CAS  PubMed  Google Scholar 

  11. Schierlitz L, Dwyer PL, Rosamilia A, Murray C, Thomas E, De Souza A. Effectiveness of tension-free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstet Gynecol. 2008;112:1253–61.

    Article  PubMed  Google Scholar 

  12. Miller JJ, Botros SM, Akl MN, Aschkenazi SO, Beaumont JL, Goldberg RP. Is transobturator tape as effective as tension-free vaginal tape in patients with borderline maximum urethral closure pressure? Am J Obstet Gynecol. 2006;195:1799–804.

    Article  PubMed  Google Scholar 

  13. Homma Y. The clinical significance of the urodynamic investigation in incontinence. BJU Int. 2002;90:489–97.

    Article  CAS  PubMed  Google Scholar 

  14. McGuire EJ, Fitzpatric CC, Wan J. Clinical assessement of urethral sphincter function. J Urol. 1993;150:1542–4.

    Google Scholar 

  15. Myers DL. Female mixed urinary incontinence: a clinical review. JAMA. 2014;311:2007–14.

    Article  CAS  PubMed  Google Scholar 

  16. de Vries AM, Heesakkers JP. Contemporary diagnostics and treatment options for female stress urinary incontinence. Asian J Urol. 2018;5:41–148.

    Google Scholar 

  17. Krhut J, Zachoval R, Smith PP, Rosier PF, Valansky L, Martan A. Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn. 2014;33:507–10.

    Article  PubMed  Google Scholar 

  18. Nager CW, Brubaker L, Litman HJ. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med. 2012;336:21.

    Google Scholar 

  19. Imamura M, Williams K, Wells M, McGrother C. Lifestyle interventions for the treatment of urinary incontinence in adults. Cochrane Database Syst Rev. 2015:Cd003505.

    Google Scholar 

  20. Burkahrd FC, Bosch JLHR, Cruz F. European Association of Urology (EAU) working panel on urinary incontinence. 2012. www.uroweb.org/guidelines/online-guidelines/.

  21. Lavelle ES, Zyczynski HM. Stress urinary incontinence: comparative efficacy trials. Obstet Gynecol Clin N Am. 2016;43:45–57.

    Article  Google Scholar 

  22. Kegel AH. Progressive resistance exercise in the functional restoration of the perineal muscles. Am J Obstet Gynecol. 1948;56(2):238–48.

    Article  CAS  PubMed  Google Scholar 

  23. Dumoulin C, Hay-Smith EJ, Mac Habee-Seguin G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2014:Cd005654.

    Google Scholar 

  24. Bo K, Hilde G. Does it work in the long term?—a systematic review on pelvic floor muscle training for female stress urinary incontinence. Neurourol Urodyn. 2013;32:215–23.

    Article  PubMed  Google Scholar 

  25. Labrie J, Berghmans BL, Fischer K, Milani AL, van der Wijk I, Smalbraak DJ. Surgery versus physiotherapy for stress urinary incontinence. N Engl J Med. 2013;369:1124–33.

    Article  CAS  PubMed  Google Scholar 

  26. Choe JM, Staskin DR. Clinical usefulness of urinary control urethral insert devices. Int Urogynecol J. 1997;8:307–13.

    Article  CAS  Google Scholar 

  27. Staskin D, Bavendam T, Miller J, et al. Effectiveness of a urinary control insert in the management of stress urinary incontinence. Urology. 1996;47:629–36.

    Article  CAS  PubMed  Google Scholar 

  28. Miller J, Bavendam T. Treatment with reliance® urinary control insert: one-year experience. J Endourol. 1996;10:287–92.

    Article  CAS  PubMed  Google Scholar 

  29. Lovatsis D, Best C, Diamond P. Short-term urestaefficacy (SURE) study: a randomized controlled trial of the urestacontinence device. Int Urogynecol J. 2017;28(1):147–50.

    Article  PubMed  Google Scholar 

  30. Jones KA, Harmanli O. Pessary use in pelvic organ prolapse and urinary incontinence. Rev Obstet Gynecol. 2010;3(1):3–9.

    PubMed  PubMed Central  Google Scholar 

  31. Farrell SA, Bydock S, Amir B, Fanning C. Effectiveness of new self-positioning pessary for the management of urinary incontinence in women. Am J Obstet Gynecol. 2007;196:474.e1–8.

    Article  Google Scholar 

  32. Ghoniem G, Corcos J, Comiter C. Durability of urethral bulking agent injection for femal stress urinary incontinence: 2-year multicentre study results. J Urol. 2010;183:1444–9.

    Article  PubMed  Google Scholar 

  33. Kirchin V, Page T, Keegan P. Urethral injection therapy for stress urinary incontinence in women. Cochrane Database Syst Rev. 2012;(2):CD003881.

    Google Scholar 

  34. Davis NF, Kheradmand F, Creagh T, et al. Int Urogynecol J. 2013;24(6):913–9.

    Article  PubMed  Google Scholar 

  35. Kuhn A, Stadlmayr W, Lengsfeld D, Mueller MD. Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:503–7.

    Article  PubMed  Google Scholar 

  36. Lightner DJ. Review of the available urethral bulking agents. Curr Opin Urol. 2002;12:333–8.

    Article  PubMed  Google Scholar 

  37. de Vries AM, van Breda HM, Fernandes JG. Para-urethral injections with urolastic(R) for treatment of female stress urinary incontinence: subjective improvement and safety. Urol Int. 2017;99:91–7.

    Article  CAS  PubMed  Google Scholar 

  38. Furuta A, Jankowski RJ, Pruchnic R. The potential of muscle-derived stem cells for stress urinary incontinence. Expert Opin Biol Ther. 2007;7(10):1483–6.

    Article  CAS  PubMed  Google Scholar 

  39. Carr LK, Robert M, Kultgen PL. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol. 2013;189:595–601.

    Article  PubMed  Google Scholar 

  40. McGuire JE, Lytton B. Pubovaginal sling procedure for stress incontinence. J Urol. 1978;119(1):82–4.

    Article  CAS  PubMed  Google Scholar 

  41. Marshall VF, Marchetti AA, Krantz KE. The correction of stress incontinence by simple vesiourethral suspension. Surg Gynecol Obstet. 1949;88:509–18.

    CAS  PubMed  Google Scholar 

  42. Mainprize TC, Drutz HP. The Marshall-Marchetti-Kratz procedure: a critical review. Obstet Gynecol Surv. 1988;43:724–9.

    Article  CAS  PubMed  Google Scholar 

  43. Lapitan MC, Cody JD. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2016;(2):Cd002912.

    Google Scholar 

  44. Heesakkers J, Chapple C, Ridder DD. Practical functional urology. Switzerland: Springer; 2016. p. 392.

    Book  Google Scholar 

  45. Rehman H, Bezerra CC, Bruschini H. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2011:Cd001754.

    Google Scholar 

  46. Schimpf MO, Rahn DD, Wheeler TL. Sling surgery for stress urinary incontinence in women: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014;211:e1–e27.

    Article  Google Scholar 

  47. Petros PE, Ulmsten UI. An integral theory of female urinary incontinence. Experimental and clinical considerations. Acta Obstet Gynecol Scand Suppl. 1990;153:7–31.

    Article  CAS  PubMed  Google Scholar 

  48. Ford AA, Rogerson L, Cody JD. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2015:Cd006375.

    Google Scholar 

  49. Kristensen I, Eldoma M, Williamson T. Complications of the tension-free vaginal tape procedure for stress urinary incontinence. Int Urogynecol J. 2010;21:1353–7.

    Article  PubMed  Google Scholar 

  50. Mengerink BB, Van Leijsen SA, Vierhout ME. The impact of midurethral sling surgery on sexual activity and function in women with stress urinary incontinence. J Sex Med. 2016;13:1498–507.

    Article  PubMed  Google Scholar 

  51. van der Doelen MJ, Withagen MIJ, Vierhout ME. Results of primary versus recurrent surgery to treat stress urinary incontinence in women. Int Urogynecol J. 2015;7:997–1005.

    Article  Google Scholar 

  52. Richter HE, Albo ME, Zyczynski HM. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;362:22.

    Article  Google Scholar 

  53. Mostafa A, Agur W, Abdel-All M. Prospective randomized study of single-incision mini-sling vs tension-free vaginal tape-obturator in management of female stress urinary incontinence: a minimum of 1-year follow-up. Urology. 2013;82(3):552–9.

    Article  PubMed  Google Scholar 

  54. Zhang Y, Jiang M, Tong XW. The comparison of an inexpensive–modified transobturator vaginal tape versus TVT-O procedure for the surgical treatment of female stress urinary incontinence. Taiwan J Obstet Gynecol. 2011;50(3):318–21.

    Article  PubMed  Google Scholar 

  55. Nambiar A, Cody JD, Jeffery ST. Single-incision sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2014;(6):CD008709. https://doi.org/10.1002/14651858.CD008709.pub2.

  56. Chartier-Kastler E, Van Kerrebroeck P, Olianas R, Cosson M, Mandron E, Delorme E, et al. Artificial urinary sphincter (AMS 800) implantation for women with intrinsic sphincter deficiency: a technique for insiders? BJU Int. 2011;107:1618–26.

    Article  PubMed  Google Scholar 

  57. Phe V, Benadiba S, Roupret M, Granger B, Richard F, Chartier-Kastler E. Long-term functional outcomes after artificial urinary sphincter implantation in women with stress urinary incontinence. BJU Int. 2014;113:961–7.

    Article  PubMed  Google Scholar 

  58. Vayleux B, Luyckx F, Thélu S, Rigaud J, Bouchot O, Karam G, et al. Adjustable continence therapy in women, middle term follow-up and a new technique for balloon positioning. Prog Urol. 2010;20(7):520–6.

    Article  CAS  PubMed  Google Scholar 

  59. Islah M, Cho SY, Son H. The current role of the artificial urinary sphincter in male and female urinary incontinence. World J Mens Health. 2013;31:21–30.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Kocjancic E, Crivellaro S, Ranzoni S, Bonvini D, Grosseti B, Frea B. Adjustable continence therapy for severe intrinsic sphincter deficiency and recurrent female stress urinary incontinence: long-term experience. J Urol. 2010;184(3):1017–21.

    Article  PubMed  Google Scholar 

  61. Phé V, Nguyen K, Rouprêt M, Cardot V, Parra J, Chartier-Kastler E. A systematic review of the treatment for female stress urinary incontinence by ACT® balloon placement (Uromedica, Irvine, CA, USA). World J Urol. 2014;32(2):495–505.

    Article  PubMed  Google Scholar 

  62. Kobashi KC, Albo ME, Dmochowski RR, Ginsberg S, Goldman HB, Gomelsky A, Kraus SR, Sandhu JS, Shepler T, Treadwell JR, Vasavada S, Lemack GE. AUA guidelines. http://www.auanet.org/guidelines/stress-urinary-incontinence-(sui)-new-(aua/sufu-guideline-2017).

  63. Stewart W, Rooyen JV, Cundiff G. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36.

    Article  CAS  PubMed  Google Scholar 

  64. Payne C. Biofeedback for community dwelling individuals with urinary incontinence. Urology. 1998;51(2):35–9.

    Article  CAS  PubMed  Google Scholar 

  65. Moore EE, Jackson SL, Boyko EJ, Scholes D, Fihn SD. Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women. Obstet Gynecol. 2008;111:317–23.

    Article  PubMed  Google Scholar 

  66. Glazener CM, Lapitan MC. Urodynamic studies for management of urinary incontinence in children and adults. Cochrane Database Syst Rev. 2012:CD003195.

    Google Scholar 

  67. Marshall HJ, Beevers DG. Alpha-adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility. Br J Clin Pharmacol. 1996;42:507–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Cody JD, Richardson K, Moehrer B, Hextall A, Glazener CM. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2009:CD001405.

    Google Scholar 

  69. Movig KL, Leufkens HG, Belitser SV, Lenderink AW, Egberts AC. Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol Drug Saf. 2002;11:271–9.

    Article  CAS  PubMed  Google Scholar 

  70. Tsakiris P, de la Rosette JJ, Michel MC, Oelke M. Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence. Eur Urol. 2008;53:53–9.

    Article  CAS  PubMed  Google Scholar 

  71. Imamura M, Abrams P, Bain C, et al. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess. 2010;14:1–188, iii–iv.

    Article  CAS  PubMed  Google Scholar 

  72. Price N, Dawood R, Jackson SR. Pelvic floor exercise for urinary incontinence: a systematic literature review. Maturitas. 2010;67(4):309–15.

    Article  PubMed  Google Scholar 

  73. Andersson KE. Advances in the pharmacological control of the bladder. Exp Physiol. 1999;84:195–213.

    Article  CAS  PubMed  Google Scholar 

  74. Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 1998;50:279–90.

    CAS  PubMed  Google Scholar 

  75. Gospel M, Gronewald A, Krege S, Michel MC. Muscarinic receptor subtypes in porcine detrusor: comparison with humans and regulation by bladder augmentation. Urol Res. 1998;26:149–54.

    Article  Google Scholar 

  76. Anderson RU, David M, Blank B. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. J Urol. 1999;161(6):1809–12.

    Article  CAS  PubMed  Google Scholar 

  77. Harvey MA, Baker K, Wells GA, et al. Am J Obstet Gynecol. 2001;185(1):57–61.

    Google Scholar 

  78. Pakulski C, Drobnik L, Millo B. Age and sex as factors modifying the function of the blood-cerebrospinal fluid barrier. Med Sci Monit. 2000;6:314–8.

    CAS  PubMed  Google Scholar 

  79. Asimakopoulos AD, Cerruto MA, Del Popolo G, La Martina M, Artibani W, Carone R, et al. An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity. Urol Int. 2012;89:259–69.

    Article  CAS  PubMed  Google Scholar 

  80. Pietzko A, Dimpfel W, Schwantes U, Topfmeier P. Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol. 1994;47:337–43.

    Article  CAS  PubMed  Google Scholar 

  81. Takasu T, Ukai M, Sato S. Effect of ®-2-(2-aminothiazol-4-yl)4-… a novel selective β3 adrenoceptor agonist on bladder function. J Pharmacol Exp Ther. 2007;321:642–7.

    Article  CAS  PubMed  Google Scholar 

  82. Sacco E, Bienstinesi R, Tienforti D, Racioppi M, Gulino G, D’Agostino D. Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence. Expert Opin Drug Discov. 2014;9(4):433–48.

    Article  CAS  PubMed  Google Scholar 

  83. Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn. 2014;33(1):17–30.

    Article  CAS  PubMed  Google Scholar 

  84. Chapple CR, Dvorak V, Radziszewski P, Van Kerrebroeck P, Wyndaele JJ, Bosman B, Boerrigter P, Drogendijk T, Ridder A, Van Der Putten-Slob I, Yamaguchi O, Dragon Investigator Group. A phase II dose-ranging study of mirabegron in patients with overactive bladder. Int Urogynecol J. 2013;24:1447–58.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Robinson D, Kelleher C, Staskin D, Mueller ER, et al. Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients. Neurourol Urodyn. 2018;37:394–406.

    Article  CAS  PubMed  Google Scholar 

  86. Dickinson J, Lewand M, Sawamoto T, Krauwinkel W, Schaddelee M. Effects of renal or hepatic impairment on the pharmacokinetics of mirabegron. Clin Drug Investig. 2013;33(1):11–23.

    Article  CAS  PubMed  Google Scholar 

  87. Wagg A, Franks B, Ramos B, Berner T. Persistence and adherance with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: early experience in Canada. Can Urol Assoc J. 2015;9:343–50.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Burgio KL, Kraus SR, Menefee S, Borello-France D, Corton M, et al. Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a radomized trial. Ann Intern Med. 2008;193(3):161–9.

    Article  Google Scholar 

  89. Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmit trial. J Urol. 2010;183:1438–43.

    Article  PubMed  Google Scholar 

  90. Ambundsen CL, Komesu YM, Chermansky C, et al. Two-year outcomes of sacral neurmodulation versus onabotulinumtoxin A for refractory urgency urinary incontinence: a randomized trial. Eur Urol. 2018:66–73.

    Google Scholar 

  91. Montecucco C, Molgó J. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol. 2005;5(3):274–9. https://doi.org/10.1016/j.coph.2004.12.006.

    Article  CAS  PubMed  Google Scholar 

  92. Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating derusor hyperreflexia in a spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164:692–7.

    Article  CAS  PubMed  Google Scholar 

  93. Dmochowski RR, Chapple C, Nitti V, Chancellor M, Everaert K, et al. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo-controlled, randomized, dose ranging trial. J Urol. 2010;184:2416–22.

    Article  CAS  PubMed  Google Scholar 

  94. Kennelly M, Dmochowski R, Schulte-Baekloh H. Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: final results of a long-term extension study. Neurourol Urodyn. 2017;36(2):368–75.

    Article  CAS  PubMed  Google Scholar 

  95. Osborn DJ, Kaufman MK, Mock S, Guan MJ, Dmochowski RR, Reynolds WS. Urinary retention rate after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of outcome. Neurourol Urodyn. 2015;34:675–8.

    Article  CAS  PubMed  Google Scholar 

  96. Tizzoni G, Foggi A. Die wiederhestellung der harnblase. Centralbl F Chir. 1888;15:921–3.

    Google Scholar 

  97. Couvelaire R. La petite vessie des tuberculeux genitourinaires:essai de classi®cation, places et variantes des cysto-intestinoplasties. J Urol (Paris). 1950;56:381–434.

    CAS  Google Scholar 

  98. Neuhof H. Fascia transplantation into a visceral defect. Surg Gynecol Obstet. 1917;24:383–4.

    Google Scholar 

  99. Elbahnasy AM, Shalhav A, Hoenig DM, et al. Bladder wall substitution with synthetic and non-intestinal organic materials. J Urol. 1998;159:628–37. 520 T.J. GREENWELL et al. # 2001 BJU International 88, 511±525.

    Article  CAS  PubMed  Google Scholar 

  100. Barrett DM, Donovan MG. Prosthetic bladder augmentation and replacement. Semin Urol. 1984;2:167–75.

    CAS  PubMed  Google Scholar 

  101. Swami KS, Feneley RC, Hammonds JC, et al. Detrusor myectomy for detrusor overactivity: a minimum 1 year follow up. Br J Urol. 1998;81:68–72.

    Article  CAS  PubMed  Google Scholar 

  102. Khoury JM, Webster GD. Augmentation cystoplasty. World J Urol. 1990;8:203–4.

    Article  Google Scholar 

  103. Kuss R, Bitker M, Camey M, et al. Indications and early and late results of intestinocystoplasty: a review of 185 cases. J Urol. 1970;103:53–63.

    Article  CAS  PubMed  Google Scholar 

  104. Smith RB, van Cangh P, Skinner DG, et al. Augmentation cystoplasty: a. critical review. J Urol. 1977;118:35–9.

    Article  CAS  PubMed  Google Scholar 

  105. Hasan ST, Marshall C, Robson WH. Clinical outcome and quality of life following enterocystoplasty for idiopathic detrusor instability and neurogenic bladder dysfunction. Br J Urol. 1995;76:551–7.

    Article  CAS  PubMed  Google Scholar 

  106. Awad SC, Al-Zahrani HM, Gajewski JB, et al. Long term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol. 1998;81:569–73.

    Article  CAS  PubMed  Google Scholar 

  107. Beier-Holgersen R, Kirkeby LT, Nordling J. Clam ileocystoplasty. Scand J Urol Nephrol. 1994;28:55–8.

    Article  CAS  PubMed  Google Scholar 

  108. Greenwell TJ, Venn SN, Mundy AR. Augmentation cystoplasty. BJU Int. 2001;88:511–25.

    Article  CAS  PubMed  Google Scholar 

  109. Chaliha C, Khullar V. Mixed incontinence. Urology. 2004;63:51–7.

    Article  PubMed  Google Scholar 

  110. Karram MM, Bhatia NN. Management of coexistent stress and urge urinary incontinence. Obstet Gynecol. 1989;73:4–7.

    CAS  PubMed  Google Scholar 

  111. Coyne KS, Zhou Z, Thompson C, Versi E. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int. 2003;92:731–5.

    Article  CAS  PubMed  Google Scholar 

  112. Dooley Y, Lowenstein L, Kenton K, et al. Mixed incontinence is more bothersome than pure incontinence subtypes. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1359–62.

    Article  PubMed  Google Scholar 

  113. Gomelsky A, Dmochowski R. Treatment of mixed urinary incontinence in women. Curr Opin Obstet Gynecol. 2011;23(5):371–5.

    PubMed  Google Scholar 

  114. Adekanmi OA, Freeman RM, Bombieri L. How colposuspensions are performed in the UK: a survey of gynecologists’ practice. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:151–19.

    Article  CAS  PubMed  Google Scholar 

  115. Khan MS, Chaliha C, Leskova L, Khullar V. The relationship between urinary symptom questionnaires and urodynamic diagnoses: an analysis of two methods of questionnaire administration. BJOG. 2004;111:468–74.

    Article  PubMed  Google Scholar 

  116. Khullar V, Hill S, Laval KU, et al. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology. 2004;64:269–74.

    Article  PubMed  Google Scholar 

  117. Dmochowski RR, Davila GW, Zinner NR, et al. Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. J Urol. 2002;168:580–6.

    Article  CAS  PubMed  Google Scholar 

  118. Langer R, Ron-El R, Bukovsky I, Caspi E. Colposuspension in patients with combined stress incontinence and detrusor instability. Eur Urol. 1988;14:437–9.

    Article  CAS  PubMed  Google Scholar 

  119. Colombo M, Zanetta G, Vitobello D, Milani R. The Burch colposuspension for women with and without detrusor overactivity. Br J Obstet Gynaecol. 1996;103:255–60.

    Article  CAS  PubMed  Google Scholar 

  120. Fulford SC, Flynn R, Barrington J, et al. An assessment of the surgical outcome and urodynamic effects of the pubovaginal sling for stress incontinence and the associated urge syndrome. J Urol. 1999;162:135–7.

    Article  CAS  PubMed  Google Scholar 

  121. McGuire EJ, Savastano JA. Stress incontinence and detrusor instability urge incontinence. Neurourol Urodyn. 1985;4:313–6.

    Article  Google Scholar 

  122. Amundsen CL, Visco AG, Ruiz H, Webster GD. Outcome in 104 pubovaginal slings using freeze-dried allograft fascia lata from a single tissue bank. Urology. 2000;56(Suppl 6A):2–8.

    Article  CAS  PubMed  Google Scholar 

  123. Barnes NM, Dmochowski RR, Park R, Nitti VW. Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms. Urology. 2002;59:856–60.

    Article  PubMed  Google Scholar 

  124. Holmgren C, Nilsson S, Lanner L, Hellberg D. Long-term results with tension- free vaginal tape on mixed and stress urinary incontinence. Obstet Gynecol. 2005;106:38–43.

    Article  PubMed  Google Scholar 

  125. Gamble TL, Botros SM, Beaumont JL, et al. Predictors of persistent detrusor overactivity after transvaginal sling procedures. Am J Obstet Gynecol. 2008;199:696.e1–7.

    Article  Google Scholar 

  126. Gambacciani M, Levancin M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric. 2015;18:757–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Fistonic N, Fistonic I, Gustek S. Minimally invasive, non-ablative Er: YAG laser treatment of stress urinary incontinence in women—a pilot study. Lasers Med Sci. 2016;31:635–43.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Krhut J, Gartner M, Mokris J. Effect of severity of urinary incontinence on quality of life in women. Neurourol Urodyn. 2018;37(6):1925–30.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vanderbilt University Medical Center, Nashville, TN, USA

    Sophia Delpe Goodridge & Roger Dmochowski

Authors
  1. Sophia Delpe Goodridge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger Dmochowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sheffield Teaching Hospitals NHS Foundation, Sheffield, UK

    Christopher R. Chapple

  2. Department of Urology, University of Virginia, Charlottesville, VA, USA

    William D. Steers

  3. Department of Urologic Surgery, University of California, Davis, Sacramento, CA, USA

    Christopher P. Evans

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Goodridge, S.D., Dmochowski, R. (2020). Contemporary Management of Urinary Incontinence. In: Chapple, C., Steers, W., Evans, C. (eds) Urologic Principles and Practice. Springer Specialist Surgery Series. Springer, Cham. https://doi.org/10.1007/978-3-030-28599-9_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28599-9_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28598-2

  • Online ISBN: 978-3-030-28599-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation